Geron | GERN - Cost Of Sales


Geron reported $1.69M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Amgen USD 1.6B 187M Mar/2026
Bio Techne USD 103.13M 1.47M Mar/2026
Cassava Sciences USD 3.96M 1.16M Sep/2025
Cytokinetics USD 160K 104.24M Mar/2026
Exelixis USD 19.95M 6.53M Mar/2026
Genmab DKK 81M 23M Dec/2025
Geron USD 1.69M 386K Mar/2026
Gilead Sciences USD 1.44B 174M Mar/2026
Incyte USD 104.5M 16.68M Mar/2026
MacroGenics USD 9.53M 585K Mar/2026
Novartis USD 3.46B 83M Mar/2026
Novavax USD 22.1M 608K Dec/2025